Home › The Boston Foundation For Sight, Inc. › BostonSight PROSE
BostonSight PROSE
The Boston Foundation For Sight, Inc. · Model 02 · UDI-DI 10850085735239
HQD
Prescription
1
510(k) clearances
134
Adverse events
5
Recalls
36
Facilities
Description
BostonSight PROSE for daily wear, fabricated from Optimum Extra (roflufocon D) - Clear- THP coated
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-06-10 | Boston Foundation For Sight | Select orders of lenses were manufactured with errors impacting sagittal height, haptics, or both. |
| 2025-06-10 | Boston Foundation For Sight | Select orders of lenses were manufactured with errors impacting sagittal height, haptics, or both. |
| 2018-07-03 | Alden Optical | Vials labeled for the prescriptions contained incorrect lenses |
| 2018-07-03 | Alden Optical | Vials labeled for the prescriptions contained incorrect lenses |
| 2010-04-20 | Bausch & Lomb Inc | The amount of D&C #6 Dye added to the formulation exceeded specified amounts. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.